FILINGS
| BCRX 0000882796 | |||
|---|---|---|---|
| Filing Date | Form Type | Description | Document |
| 2018-11-06 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-11-06 | 8-K | FORM 8-K | View Document |
| 2018-11-05 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-10-31 | 8-K | FORM 8-K | View Document |
| 2018-10-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-10-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-10-04 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-09-28 | DEF 14A | DEF 14A | View Document |
| 2018-09-18 | PRE 14A | PRELIMINARY PROXY STATEMENT | View Document |
| 2018-09-17 | 8-K | FORM 8-K | View Document |
| 2018-09-06 | 8-K | FORM 8-K | View Document |
| 2018-09-04 | 8-K/A | FORM 8-K/A | View Document |
| 2018-09-04 | 8-K | FORM 8-K | View Document |
| 2018-08-13 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-08-09 | 10-Q | FORM 10-Q | View Document |
| 2018-08-07 | 8-K | FORM 8-K | View Document |
| 2018-08-06 | SC 13G/A | SC 13G/A | View Document |
| 2018-08-06 | 8-K | FORM 8-K | View Document |
| 2018-08-06 | 8-K | FORM 8-K | View Document |
| 2018-08-03 | 424B2 | 424B2 | View Document |
| 2018-08-01 | 424B5 | FORM 424B5 | View Document |
| 2018-07-31 | SC 13D/A | View Document | |
| 2018-07-26 | 8-K | FORM 8-K | View Document |
| 2018-07-20 | 8-K | FORM 8-K | View Document |
| 2018-07-11 | 8-K | FORM 8-K | View Document |
| 2018-07-10 | 8-K | FORM 8-K | View Document |
| 2018-07-10 | SC 13G/A | JANUS HENDERSON GROUP PLC OWNS 11.2% BIOCRYST | View Document |
| 2018-06-22 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-06-22 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-06-22 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-06-22 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-06-22 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-06-22 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-06-21 | 425 | 425 | View Document |
| 2018-06-21 | 425 | 425 | View Document |
| 2018-06-20 | 8-K | FORM 8-K | View Document |
| 2018-06-20 | SC 13D/A | View Document | |
| 2018-06-11 | 425 | 425 | View Document |
| 2018-06-11 | 425 | 425 | View Document |
| 2018-06-07 | 425 | 425 | View Document |
| 2018-06-07 | 425 | 425 | View Document |
| 2018-06-07 | 425 | 425 | View Document |
| 2018-06-06 | CT ORDER | View Document | |
| 2018-06-05 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-06-05 | 425 | 425 | View Document |
| 2018-06-04 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-06-04 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-05-30 | DEFM14A | DEFM14A | View Document |
| 2018-05-24 | 8-K | FORM 8-K | View Document |
| 2018-05-21 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-05-17 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-05-10 | DEFA14A | DEFA14A | View Document |
| 2018-05-10 | DEF 14A | DEFINITIVE PROXY STATEMENT | View Document |
| 2018-05-09 | 10-Q | FORM 10-Q | View Document |
| 2018-05-09 | 425 | 425 | View Document |
| 2018-05-08 | 425 | FORM 425 FOR BIOCRYST PHARMACEUTICALS INC | View Document |
| 2018-05-08 | 425 | FORM 425 FOR BIOCRYST PHARMACEUTICALS INC | View Document |
| 2018-05-08 | 8-K | FORM 8-K | View Document |
| 2018-05-01 | 8-K | FORM 8-K | View Document |
| 2018-04-10 | 425 | 425 | View Document |
| 2018-04-10 | 425 | 425 | View Document |
| 2018-04-06 | CT ORDER | View Document | |
| 2018-04-02 | 425 | 425 | View Document |
| 2018-04-02 | 425 | 425 | View Document |
| 2018-04-02 | SC 13D | View Document | |
| 2018-04-02 | 425 | 425 | View Document |
| 2018-04-02 | 425 | 425 | View Document |
| 2018-03-29 | DEFM14A | DEFM14A | View Document |
| 2018-03-27 | 10-K/A | FORM 10-K/A | View Document |
| 2018-03-22 | 425 | 425 | View Document |
| 2018-03-22 | 425 | 425 | View Document |
| 2018-03-15 | 8-K | FORM 8-K | View Document |
| 2018-03-12 | 10-K | FORM 10-K | View Document |
| 2018-03-08 | 425 | 425 | View Document |
| 2018-03-08 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-03-07 | 425 | 425 | View Document |
| 2018-03-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-03-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-03-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-03-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-02-28 | 425 | View Document | |
| 2018-02-28 | 8-K | FORM 8-K | View Document |
| 2018-02-27 | 425 | 425 | View Document |
| 2018-02-27 | 425 | 425 | View Document |
| 2018-02-27 | 8-K | 8-K | View Document |
| 2018-02-27 | 425 | 425 | View Document |
| 2018-02-27 | 425 | 425 | View Document |
| 2018-02-27 | 425 | 425 | View Document |
| 2018-02-27 | 425 | 425 | View Document |
| 2018-02-23 | 425 | 425 | View Document |
| 2018-02-22 | 425 | FORM 425 FOR BIOCRYST PHARMACEUTICALS INC | View Document |
| 2018-02-22 | 425 | 425 | View Document |
| 2018-02-22 | 425 | 425 | View Document |
| 2018-02-20 | 425 | 425 | View Document |
| 2018-02-16 | SC 13D | View Document | |
| 2018-02-14 | SC 13G | SC 13G | View Document |
| 2018-02-14 | SC 13G/A | SC 13G/A | View Document |
| 2018-02-14 | SC 13G/A | View Document | |
| 2018-02-14 | SC 13G/A | View Document | |
| 2018-02-14 | SC 13G/A | SC 13G/A | View Document |
Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.
